Clinical trial
Effects of Imatinib Mesylate in Polycythemia Vera
NCT00430066 · Niguarda Hospital, Other · Completed
Key facts
| NCT number | NCT00430066 |
|---|---|
| Title | Effects of Imatinib Mesylate in Polycythemia Vera |
| Official title | Glivec (Imatinib Mesylate) in the Treatment of Polycythemia Vera |
| Lead sponsor | Niguarda Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Polycythemia Vera |
| Intervention type | Drug |
| Interventions | Imatinib Mesylate |
| Enrollment | 9 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Sep 1, 2012 |
| First posted | Feb 1, 2007 |
| Last update posted | Oct 8, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: